Werkgroep Cardiologische centra Nederland

SOLOIST-WHF (Follow-up)

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST Worsening Heart Failure
Medicine
sotagliflozin
Population
Heart failure
Phase
III
Starting year
2017
More information
Clinicaltrials.gov